rfhg_2502.1

Basic information about the TSS

---

TSS ID: rfhg_2502.1 Species: human Chr: chr1		Start: 19168055 End: 19168138 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000417040.1:0 GeneID: 23352 HGNC/MGI_ID: HGNC:30313 UniProt_ID: A0A0A0MSW0 Nearer transcript ids and distances:

Gene_name: ubiquitin protein ligase E3 component n-recognin 4 Gene_symbol: UBR4 Gene_synonyms: KIAA0462 KIAA1307 RBAF600 p600 Gene_source: HGNC:30313

TATA-Box annotation

---

Distance to TSS:	42170
Nearest PromoterID:	NM_020765
Entrez ID:	23352
Nearest Unigene:	Hs.148078
Nearest Refseq:	NM_020765
Nearest Ensembl:	ENSG00000127481
Gene Name:	ubiquitin protein ligase E3 component n-recognin 4
Gene Alias:	RBAF600|ZUBR1|p600
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.607143
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBR4 p2@UBR4 p3@UBR4 p4@UBR4 p5@UBR4 p6@UBR4
Sample		p1@UBR4	p2@UBR4	p3@UBR4	p4@UBR4	p5@UBR4	p6@UBR4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	87.66	1.75	3.12	0.00	1.75	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	99.95	2.43	3.24	0.00	1.62	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	98.19	1.35	1.54	0.00	2.70	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	96.68	2.29	2.08	0.00	1.87	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	95.39	2.02	2.70	0.00	1.57	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	87.99	1.55	3.68	0.00	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	94.34	2.83	3.05	0.00	2.83	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	106.33	2.42	2.66	0.00	1.94	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	122.25	3.85	1.92	0.21	2.35	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	220.26	9.85	5.80	0.00	3.48	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	213.44	2.83	6.87	0.00	3.23	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	263.45	5.29	5.29	0.00	2.44	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	92.52	6.29	2.58	0.00	2.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	83.44	4.36	3.16	0.00	1.20	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	88.48	3.07	3.95	0.00	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	70.17	2.01	3.52	0.00	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	62.25	2.18	1.97	0.00	1.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	64.96	3.80	3.37	0.00	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	64.51	2.13	2.13	0.00	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	78.38	4.21	2.56	0.00	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	71.90	3.34	3.88	0.00	1.74	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.99	2.93	2.24	0.00	1.90	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.47	3.49	2.20	0.13	1.29	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	62.12	2.91	2.18	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	79.98	4.13	1.55	0.00	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	72.80	4.43	1.90	0.00	1.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	75.83	3.30	1.65	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	83.93	4.95	3.54	0.00	1.89	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	70.91	2.10	2.91	0.00	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	72.93	3.98	2.35	0.00	1.27	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	71.39	2.72	2.30	0.00	1.88	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	77.76	4.49	2.93	0.00	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	74.70	3.38	2.95	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	54.27	2.64	1.98	0.00	0.99	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	75.73	3.93	2.24	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	67.83	3.07	1.72	0.00	1.34	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	61.72	1.02	3.07	0.00	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	51.58	2.01	2.22	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	69.15	2.70	2.43	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	65.54	2.88	1.92	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	58.58	3.06	2.59	0.00	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	64.71	2.34	2.05	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	73.18	2.95	1.69	0.00	1.90	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	77.62	2.97	4.55	0.00	2.27	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.90	4.82	3.21	0.00	1.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	70.03	4.65	1.86	0.23	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	63.82	3.84	2.40	0.00	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	62.89	3.58	2.38	0.00	1.79	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	76.84	2.87	2.87	0.00	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	87.96	3.84	2.63	0.00	1.42	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	92.23	2.66	4.51	0.00	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	108.52	2.45	4.23	0.00	2.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	77.36	2.84	4.61	0.00	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	70.92	3.31	3.31	0.00	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	46.14	1.68	0.00	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	85.42	2.30	4.59	0.00	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	69.68	2.59	3.89	0.00	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	70.01	2.89	5.14	0.00	2.25	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	104.99	2.51	2.51	0.00	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	79.67	2.12	4.23	0.00	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	75.15	2.24	1.68	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	167.99	1.59	2.39	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	146.44	3.06	6.12	0.00	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	95.85	4.22	3.57	0.00	2.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	70.64	3.55	2.13	0.00	2.13	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	205.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	72.15	0.49	3.90	0.00	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	83.80	0.50	2.98	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	72.71	1.88	3.28	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	93.06	2.65	3.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	84.76	1.86	1.24	0.00	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	79.49	3.67	2.45	0.31	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	53.06	2.22	1.43	4.59	1.43	0.95
Adipocyte - breast, donor2	11327-117E4	51.66	2.41	1.28	3.21	0.80	0.16
Adipocyte - omental, donor1	11473-119C6	74.94	4.71	2.42	3.69	2.93	0.38
Adipocyte - omental, donor2	11474-119C7	29.15	2.24	2.99	5.98	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	59.62	4.35	4.02	1.67	1.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	29.35	2.55	0.64	1.91	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	0.00	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	29.81	0.45	0.90	1.35	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	25.89	0.87	1.22	1.39	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	104.24	7.82	4.50	6.06	1.76	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	80.56	4.38	2.06	6.43	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	95.90	4.46	3.62	21.47	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	110.51	2.94	2.94	11.17	2.35	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	83.33	4.75	4.10	4.02	2.73	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	79.72	1.94	1.94	9.36	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	76.25	2.13	1.60	6.93	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	105.17	3.90	4.45	3.34	2.78	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	56.15	1.66	3.74	1.66	1.66	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	66.81	3.77	2.26	12.31	1.76	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	80.18	2.95	1.64	7.85	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	69.42	4.26	2.74	5.18	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	39.34	1.77	1.77	0.88	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	27.61	2.87	2.15	1.43	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	1.20	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	55.05	3.24	2.34	7.38	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	0.00	1.67	6.69	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	43.97	2.47	1.23	8.83	0.82	0.21
Anulus Pulposus Cell, donor1	11248-116E6	21.63	1.14	1.37	0.00	1.60	0.34
Anulus Pulposus Cell, donor2	11463-119B5	33.55	2.45	0.49	0.00	1.96	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.49	1.80	1.80	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	37.77	1.74	2.17	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.60	1.79	1.20	1.20	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	36.67	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	0.66	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.97	0.97	1.95	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	41.26	0.00	2.91	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	2.38	0.00	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	30.88	2.26	1.88	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.83	0.73	1.45	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	0.00	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.16	1.32	0.99	0.49	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	2.73	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	31.82	1.96	1.66	0.15	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.97	3.21	2.14	0.54	1.61	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.23	1.89	1.32	0.57	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.13	0.27	1.07	0.80	1.34	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	0.98	3.90	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.86	2.49	1.33	0.83	1.16	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	32.42	1.54	0.86	0.34	0.51	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	40.78	3.88	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.11	1.90	0.76	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	38.76	1.71	1.14	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.49	1.50	1.50	0.86	1.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	23.49	1.29	0.00	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.15	1.88	0.94	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	29.58	2.25	0.64	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.97	0.00	0.71	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	26.32	1.17	1.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.21	1.51	0.60	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	21.87	0.00	2.54	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.33	2.04	0.25	0.51	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.23	0.64	0.00	3.18	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.34	2.16	1.29	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	27.10	1.91	1.06	0.85	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.30	1.45	0.58	0.87	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	0.00	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.60	0.85	1.53	0.00	1.02	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.88	1.72	2.57	0.86	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	29.48	0.60	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.53	1.84	0.46	0.23	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	28.98	1.53	1.53	1.53	1.27	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.06	1.86	1.65	0.83	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.46	1.22	0.00	0.61	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.20	2.39	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.26	1.55	0.89	0.22	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	39.88	1.66	2.22	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	29.13	2.38	1.32	0.26	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.62	0.73	1.09	0.36	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	36.60	3.56	4.30	0.00	2.33	1.35
Astrocyte - cerebellum, donor2	11580-120F5	30.64	2.23	2.74	0.00	2.05	0.51
Astrocyte - cerebellum, donor3	11661-122F5	29.78	0.84	1.47	0.00	1.89	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	50.54	2.79	1.39	0.00	1.74	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	54.36	2.26	3.56	0.00	3.40	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	71.75	3.88	3.13	0.00	2.54	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	84.75	5.62	5.16	0.00	3.10	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	78.68	6.51	5.14	0.00	2.26	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	75.67	4.21	4.78	0.00	1.37	0.34
Basophils, donor1	12241-129G9	145.67	8.37	3.66	22.75	0.78	0.00
Basophils, donor2	12242-129H1	192.66	6.13	3.61	21.29	0.72	1.08
Basophils, donor3	12243-129H2	114.80	9.41	4.12	19.70	1.03	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	37.73	1.94	2.59	0.86	1.29	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	25.60	1.37	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	28.87	1.88	0.63	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	48.45	1.87	2.08	0.00	1.66	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	61.49	2.53	3.91	0.23	2.53	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	40.49	2.34	3.06	1.62	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	63.89	3.71	5.77	0.00	3.19	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	192.38	11.65	14.91	0.00	7.92	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	99.77	5.76	4.48	0.32	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	295.30	15.78	5.07	15.22	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	222.91	13.55	4.08	15.03	2.04	0.00
CD14+ Monocytes, donor3	11381-118B4	224.37	13.17	3.73	11.64	1.10	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	76.99	2.55	3.96	23.49	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	99.70	7.58	4.17	17.82	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	93.69	7.23	3.62	23.34	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	135.30	4.63	4.34	41.20	1.16	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	122.81	5.43	3.62	27.76	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	155.16	5.45	3.55	24.87	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	164.22	5.52	4.35	32.48	1.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	183.82	8.00	1.93	31.47	1.38	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	209.75	10.91	3.47	29.01	2.48	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	147.44	6.46	6.07	22.13	1.17	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	158.46	6.59	3.03	21.90	1.07	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	155.17	8.27	2.18	18.28	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	211.18	8.90	4.92	21.07	1.87	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	229.16	11.09	4.22	20.59	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	206.34	11.09	5.55	21.08	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	125.69	4.31	2.53	42.10	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	139.28	5.59	3.39	33.12	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	126.59	4.58	3.54	27.07	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	207.97	10.30	3.20	26.08	1.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	194.08	6.56	3.17	25.79	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	187.68	7.86	2.18	9.17	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	146.87	6.72	3.77	16.41	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	167.13	6.11	3.49	24.42	0.87	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	176.74	5.89	2.10	16.41	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	242.31	12.68	4.23	24.98	1.65	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	314.57	19.73	6.69	21.84	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	358.00	14.92	9.65	14.92	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	153.62	5.58	2.79	33.13	1.22	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	144.95	6.69	1.86	24.16	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	164.25	7.33	3.23	33.63	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	249.38	13.92	5.73	19.25	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	255.67	13.44	5.10	23.18	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	264.24	14.15	5.10	13.92	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	64.52	3.05	1.74	6.10	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	81.31	3.46	2.08	6.47	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	72.13	3.68	1.08	7.80	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	118.35	6.07	3.58	60.42	1.09	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	95.01	4.54	2.45	43.49	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	163.88	7.80	4.68	35.90	1.34	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	78.34	4.59	2.81	0.51	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	72.02	3.73	1.54	0.22	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	72.64	4.63	1.68	0.63	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	101.62	2.03	6.10	6.10	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	108.48	6.78	2.03	1.36	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	95.27	3.11	5.18	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	102.34	6.40	3.73	3.73	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	79.34	4.82	3.22	0.54	1.07	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	105.99	4.21	2.81	0.70	2.11	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	79.22	3.92	1.57	0.78	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	5.27	7.91	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	287.67	9.04	4.93	2.47	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	254.63	9.43	5.08	4.35	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	260.49	9.09	4.54	0.50	3.03	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	230.72	12.12	7.68	1.62	3.64	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	159.80	14.38	9.19	2.40	3.20	0.00
CD34+ Progenitors, donor1	11545-120B6	185.75	11.04	3.01	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	253.94	10.67	2.81	1.12	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	86.05	7.14	5.64	3.76	0.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	99.21	3.83	5.19	3.61	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	315.28	6.78	7.50	0.00	2.50	1.43
CD4+ T Cells, donor2	11306-117C1	237.60	4.90	2.45	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	247.65	7.93	5.18	0.00	0.30	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	128.13	7.66	5.10	0.77	0.51	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	124.43	8.76	5.61	0.00	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	142.29	7.19	4.31	0.00	0.86	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	182.53	6.16	1.42	0.00	1.90	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	200.16	4.21	4.21	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	214.25	6.59	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	107.66	2.75	3.03	0.00	1.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	97.61	4.91	2.88	0.17	0.85	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	94.47	5.80	3.06	0.00	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	132.25	3.14	4.03	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	125.78	3.84	3.84	0.00	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	183.47	6.16	5.28	0.00	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	155.59	2.95	3.37	0.00	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	109.49	5.19	4.36	0.00	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	98.23	3.68	4.01	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	217.82	7.61	4.35	0.00	0.27	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	264.76	8.04	6.43	0.54	2.14	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	204.43	8.97	10.76	0.00	3.59	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	129.99	5.38	3.89	0.00	1.30	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	105.49	3.47	3.47	0.00	0.65	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	105.08	4.62	4.83	0.00	0.42	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	163.31	5.06	4.55	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	159.44	7.80	2.60	0.00	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	208.32	5.23	3.92	0.00	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	139.55	5.94	6.43	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	142.17	8.31	6.46	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	125.62	4.19	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	150.93	9.42	8.86	3.32	1.11	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	192.63	12.27	8.59	2.21	2.70	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	166.32	21.56	6.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	130.35	4.66	4.66	2.51	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	153.73	12.46	8.31	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	274.03	8.51	9.17	0.00	2.62	1.31
CD8+ T Cells, donor2	11307-117C2	222.63	5.26	4.88	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	280.01	8.58	5.05	0.00	1.51	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	66.75	2.29	1.61	0.00	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	62.55	2.64	1.20	0.00	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	54.44	3.01	2.74	0.00	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	43.83	1.20	2.70	0.00	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	72.47	3.36	1.92	0.00	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	69.35	0.45	2.73	0.00	1.36	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	76.70	4.13	2.17	0.00	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	82.38	5.00	1.58	0.00	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	83.72	2.35	2.11	0.00	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	72.75	2.72	2.72	0.00	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	69.43	1.45	2.32	0.00	1.16	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.60	1.33	1.60	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	188.23	7.44	4.82	0.00	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	185.36	10.02	5.92	0.00	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	196.91	5.22	5.22	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	72.75	2.52	2.88	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	74.52	2.88	2.88	0.00	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	73.77	3.77	3.54	0.00	0.94	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	100.78	4.12	4.44	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	95.65	4.61	2.15	0.00	1.85	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	100.98	3.53	2.24	0.00	1.60	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	91.03	3.06	6.50	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	93.80	1.97	4.73	0.00	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	80.18	0.76	4.54	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	259.35	12.85	9.64	0.00	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	225.22	7.69	3.50	0.00	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	320.56	10.02	8.01	0.00	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	76.77	5.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	30.14	0.99	1.48	9.88	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	19.68	1.26	0.84	0.21	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	58.93	2.08	4.16	0.00	1.73	0.35
Chondrocyte - de diff, donor2	11338-117F6	52.95	3.20	3.20	0.00	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	37.09	1.02	1.14	0.00	1.02	0.23
Chondrocyte - re diff, donor2	11339-117F7	109.22	4.48	1.79	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	79.26	2.02	3.64	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	53.94	3.21	3.90	0.00	3.67	3.10
Ciliary Epithelial Cells, donor2	11323-117D9	41.68	2.35	3.63	0.00	2.35	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	51.86	2.30	2.48	0.09	2.04	2.12
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	127.19	9.45	13.02	1.01	14.40	2.48
Corneal Epithelial Cells, donor1	11526-119I5	27.45	1.98	1.76	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	37.54	3.41	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	42.69	1.79	1.79	0.00	2.05	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	66.86	2.97	2.15	50.68	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	72.23	3.78	1.58	39.43	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	6.90	0.00	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.60	2.05	1.94	36.82	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	139.05	4.10	2.39	1.71	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	126.66	8.49	3.26	2.61	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	168.90	3.87	4.84	0.48	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	60.54	2.50	2.50	10.84	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	33.45	2.93	2.93	2.93	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	87.10	2.83	3.96	3.11	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	59.37	3.15	1.57	1.97	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	52.94	1.45	1.45	8.14	1.75	0.58
Endothelial Cells - Artery, donor2	11341-117F9	45.88	2.12	3.53	3.06	2.12	0.00
Endothelial Cells - Artery, donor3	11413-118E9	49.26	1.93	3.33	5.96	1.05	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	54.97	2.66	3.99	6.43	0.66	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	66.63	4.26	6.39	6.09	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	84.85	6.20	3.66	0.28	1.41	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	54.97	3.57	3.57	0.59	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	40.09	2.08	3.64	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	36.30	1.84	1.99	0.14	0.85	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	55.22	3.60	2.80	6.00	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	50.84	0.52	1.05	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	85.36	2.61	3.73	2.48	0.87	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	72.13	3.04	3.69	1.74	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	82.80	1.83	4.40	2.32	1.47	0.37
Endothelial Cells - Vein, donor1	11267-116G7	47.78	0.00	2.28	2.28	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	74.74	3.49	3.49	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	45.06	3.30	1.73	2.04	0.47	0.47
Eosinophils, donor1	12244-129H3	228.70	0.00	0.00	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	1231.10	54.46	26.40	3.30	3.30	1.65
Eosinophils, donor3	12246-129H5	1016.54	39.24	17.83	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	29.32	0.73	1.71	0.49	0.98	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	0.00	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	88.26	2.87	2.87	0.41	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.37	0.66	0.33	1.64	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.46	1.30	0.98	3.03	0.65	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.21	1.58	1.58	1.09	1.46	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	158.03	11.33	8.05	1.36	4.09	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.75	1.48	1.58	2.11	0.84	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	177.07	9.49	9.22	2.63	2.11	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	48.83	1.99	3.65	1.00	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	40.83	1.81	2.27	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	59.88	1.52	2.27	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	32.96	1.73	1.42	1.10	1.10	0.00
Fibroblast - Cardiac, donor4	11452-119A3	67.29	3.33	6.06	1.21	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	56.22	3.17	2.41	2.28	1.14	0.25
Fibroblast - Cardiac, donor6	11460-119B2	48.21	2.27	2.73	3.03	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	66.06	3.48	3.75	0.13	2.68	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	46.59	1.29	1.73	0.00	2.16	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	2.93	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	68.96	3.46	4.61	0.00	1.85	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	36.97	3.22	2.04	0.17	1.36	0.17
Fibroblast - Dermal, donor1	11269-116G9	26.77	2.35	1.41	7.28	1.88	0.00
Fibroblast - Dermal, donor2	11346-117G5	34.43	2.36	3.77	3.30	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.85	1.45	0.73	4.59	1.09	0.12
Fibroblast - Dermal, donor4	11450-119A1	39.91	2.37	4.07	0.11	1.13	0.34
Fibroblast - Dermal, donor5	11454-119A5	50.07	2.97	4.54	0.52	1.57	0.17
Fibroblast - Dermal, donor6	11458-119A9	50.03	2.27	1.79	0.49	1.30	0.16
Fibroblast - Gingival, donor1	11237-116D4	49.35	1.46	2.92	1.46	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	99.82	5.76	7.60	7.60	3.41	0.52
Fibroblast - Gingival, donor2	11318-117D4	40.46	1.84	1.58	0.40	0.66	0.53
Fibroblast - Gingival, donor3	11394-118C8	51.92	2.61	2.71	1.55	1.26	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	70.64	1.04	1.04	1.04	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	50.04	2.11	2.11	1.41	0.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	94.01	3.59	5.61	1.71	2.81	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	61.26	2.57	1.89	0.27	1.35	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	79.75	4.23	3.53	5.65	3.88	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	69.32	2.63	2.19	2.05	3.22	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	73.49	3.14	3.14	0.41	1.91	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	64.06	2.96	2.63	0.00	0.99	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	98.46	5.43	4.40	0.00	1.32	0.15
Fibroblast - Lung, donor1	11270-116H1	57.09	2.72	4.08	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	68.64	1.49	5.97	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	26.17	1.27	1.90	0.00	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	72.47	2.50	5.00	1.67	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	0.00	1.40	4.20	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	17.91	0.56	0.84	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	78.35	5.68	6.50	4.47	3.65	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	44.81	1.75	1.16	0.00	1.36	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	76.30	2.88	3.94	0.00	1.67	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	74.97	4.90	4.28	5.20	1.53	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	61.82	3.43	2.29	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.47	2.16	2.16	0.27	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.19	1.97	1.97	0.58	1.39	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.69	0.55	0.33	4.53	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	81.28	5.08	5.28	5.69	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.74	0.67	3.34	0.00	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	1.58	0.40	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	255.01	15.68	14.09	0.60	4.37	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.40	3.02	2.13	0.18	0.71	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.82	3.55	2.56	1.97	1.18	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	175.70	13.24	10.53	9.63	2.11	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.96	3.99	3.02	3.13	1.40	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	164.75	14.68	10.38	1.52	3.54	0.25
Fibroblast - skin normal, donor1	11553-120C5	52.83	2.95	2.13	2.13	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	207.32	13.43	9.82	4.41	5.41	0.60
Fibroblast - skin normal, donor2	11561-120D4	53.85	4.62	4.62	2.11	2.11	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	215.80	14.51	13.90	0.91	4.23	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	51.28	1.66	2.15	0.66	1.66	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	68.55	4.27	5.13	0.17	1.54	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	178.01	11.82	7.23	0.66	2.30	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.58	4.47	4.90	1.07	1.81	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	58.19	2.19	4.05	0.34	1.52	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.86	0.31	0.63	5.65	1.10	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	100.23	7.84	2.61	14.82	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	38.31	1.56	3.29	2.60	2.25	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.97	3.90	2.86	0.78	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.83	3.58	4.09	0.26	2.56	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	103.35	1.53	4.59	0.00	3.06	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	74.65	0.64	3.83	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	182.28	3.99	7.13	0.00	4.28	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	164.08	7.72	8.55	0.00	2.48	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	149.10	8.22	11.19	0.00	4.79	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	155.93	3.96	4.76	0.00	4.16	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	135.60	6.08	5.29	0.00	3.17	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	134.70	14.35	11.74	0.00	4.57	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	189.27	3.98	9.29	0.00	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	83.52	2.69	2.12	0.00	1.84	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	89.89	2.83	4.19	0.25	2.96	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	79.78	2.42	2.15	0.00	2.42	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	64.05	3.35	2.85	2.23	1.49	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	92.19	3.18	4.57	0.69	2.35	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	76.65	3.25	3.86	1.83	1.42	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.53	3.65	3.19	2.05	2.05	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	69.76	3.11	4.48	1.49	1.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	88.09	8.96	5.46	2.40	2.40	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.69	2.66	3.25	4.73	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	79.48	2.54	3.34	0.95	1.91	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	68.14	3.35	3.80	0.00	1.56	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.33	1.81	2.62	8.87	1.21	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.62	2.54	3.90	3.39	1.19	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	74.48	4.34	3.90	3.46	2.31	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.31	2.08	3.02	15.30	2.08	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.77	2.22	2.73	10.93	1.37	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	68.72	2.88	3.32	4.65	1.77	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.64	3.00	3.49	2.58	1.75	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	69.22	3.06	4.29	3.68	1.23	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	53.23	2.48	1.44	8.66	1.03	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	68.14	3.34	1.84	4.73	0.92	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	62.54	2.00	2.50	4.17	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.05	2.65	2.42	11.24	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	56.21	3.32	2.21	3.57	1.48	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	72.94	2.59	3.08	3.73	1.95	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	77.93	5.13	2.89	9.94	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	50.50	1.99	2.37	5.50	0.95	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	55.52	3.95	2.69	4.43	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	70.85	2.43	1.22	8.21	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	61.05	3.45	2.82	5.54	0.84	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	61.26	2.42	1.32	2.63	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.87	2.81	1.40	9.54	1.68	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	66.29	3.70	3.06	2.96	1.76	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.25	1.87	1.60	4.81	1.87	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	60.59	3.06	2.45	10.25	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	44.95	1.68	1.94	3.76	0.65	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	51.50	1.90	3.25	2.17	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	56.96	2.95	1.47	1.66	1.47	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	66.23	2.63	2.19	1.32	2.41	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	84.30	4.96	1.98	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.05	1.06	2.64	1.98	1.58	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	60.33	3.63	3.23	0.00	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	72.44	2.80	2.80	0.00	1.52	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	133.37	6.97	4.98	0.00	3.18	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	107.85	4.78	5.70	0.00	2.47	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	159.78	6.75	5.11	0.00	2.86	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	86.99	2.82	4.69	0.00	3.13	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	63.29	1.98	2.26	0.00	1.98	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	168.34	5.53	3.69	0.00	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	91.57	9.90	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	80.46	3.09	3.09	0.00	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	120.34	1.60	4.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	121.72	1.74	5.22	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	63.14	2.60	3.58	0.00	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	90.60	2.06	2.47	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	123.29	6.66	3.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	70.75	2.80	2.80	0.00	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	66.35	1.31	1.96	0.00	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	93.11	3.36	2.52	0.00	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	77.93	2.23	4.77	0.00	2.23	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.57	0.68	4.42	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	106.50	2.09	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	54.41	2.29	2.29	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	57.72	1.78	1.78	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	72.85	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	69.17	2.07	2.90	0.00	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	67.89	3.68	1.38	0.00	1.84	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	64.20	1.15	0.77	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	68.13	1.63	1.96	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.19	2.68	2.68	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	64.34	3.47	2.70	0.00	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	108.52	2.40	5.14	0.00	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	139.15	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	89.18	1.89	2.36	0.47	2.36	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	69.40	3.62	1.21	0.00	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	84.44	2.03	3.05	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.97	4.39	2.79	0.00	2.39	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	102.62	3.95	3.95	0.00	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	141.65	7.08	5.90	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	85.77	4.67	1.17	0.00	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	89.97	5.27	5.71	0.00	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	102.57	3.39	5.09	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	107.44	2.98	4.18	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	68.42	3.40	1.46	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	0.00	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.77	0.42	1.66	0.42	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	2.25	4.50	7.87	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.10	0.95	0.63	0.63	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	1.25	0.42	0.42	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.50	1.86	1.39	0.00	1.62	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.92	2.36	1.01	0.00	0.84	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.58	1.37	1.37	0.00	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	24.38	1.75	1.42	0.00	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.79	0.64	1.72	0.00	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.97	0.65	1.72	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.79	0.62	0.87	0.12	0.75	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.30	0.51	0.86	0.00	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	1.60	0.64	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	50.37	3.36	1.68	3.92	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.03	0.87	2.60	3.46	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	0.00	0.00	13.22	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	37.74	1.76	3.88	0.35	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	28.33	0.73	1.45	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.30	1.22	2.27	3.85	0.35	0.00
Hepatocyte, donor1	11523-119I2	82.32	3.63	2.42	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	131.44	2.15	3.23	2.15	1.08	0.00
Hepatocyte, donor3	11684-122I1	96.94	3.07	4.91	0.00	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	131.84	7.83	5.22	0.00	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	63.97	2.97	3.15	2.10	1.40	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	27.99	2.20	1.23	0.14	1.23	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	407.54	19.10	6.37	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	206.93	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	297.92	27.08	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	317.02	16.61	16.61	2.77	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	187.70	17.52	15.02	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	356.05	11.87	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	353.68	28.19	5.13	0.00	7.69	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	228.54	36.57	18.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	376.84	37.36	11.37	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	235.09	10.00	10.00	5.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	203.31	10.89	14.52	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	309.69	19.85	17.21	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	235.03	15.52	12.20	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	230.48	5.24	15.71	0.00	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	177.62	8.82	9.45	1.26	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	227.35	17.01	4.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	234.16	14.63	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	242.26	17.44	16.15	0.65	5.17	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	404.09	17.71	16.10	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	406.24	47.79	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	297.43	17.93	17.93	3.26	4.07	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	316.54	25.61	20.99	2.10	5.46	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	273.08	0.00	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	298.17	12.06	18.48	0.80	4.02	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	231.74	14.77	13.85	2.77	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	180.79	9.91	8.97	0.94	1.89	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	232.19	18.14	15.42	0.91	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	14.74	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	275.49	20.45	7.53	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	357.00	20.33	6.35	2.54	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	279.32	65.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	344.98	24.23	14.67	0.00	4.46	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	355.42	21.87	23.69	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	331.89	47.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	382.74	19.28	21.42	2.14	4.28	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	371.65	33.18	29.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	521.21	20.85	20.85	0.00	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	180.57	13.27	12.04	1.54	2.16	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	354.72	15.80	15.80	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	326.89	18.86	22.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	372.03	27.12	20.17	0.00	4.87	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	323.11	19.92	17.70	0.00	6.64	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	256.12	9.73	3.24	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	257.22	17.44	11.34	1.74	5.23	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	240.73	15.75	18.00	6.75	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	247.40	13.94	17.42	0.00	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	265.63	18.14	12.80	2.13	5.33	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	302.03	22.17	18.01	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	370.45	17.10	19.95	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	267.84	13.81	10.12	1.84	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	214.80	9.08	21.18	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	347.69	18.63	37.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	157.55	13.75	12.69	2.11	4.23	0.00
Keratinocyte - epidermal, donor1	11272-116H3	44.47	2.28	3.10	0.33	1.14	0.08
Keratinocyte - epidermal, donor2	11349-117G8	38.65	1.76	2.34	7.03	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	39.57	1.99	1.61	25.94	1.04	0.00
Keratinocyte - oral, donor1	11251-116E9	36.21	0.45	1.82	0.11	1.36	0.57
Keratocytes, donor1	11527-119I6	83.89	4.47	4.47	0.00	2.06	0.34
Keratocytes, donor2	11607-120I5	33.98	0.00	1.17	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	50.58	2.96	4.94	0.40	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	4.40	10.99	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	17.26	2.16	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	19.72	1.38	1.38	0.00	1.27	0.46
Lens Epithelial Cells, donor3	11690-122I7	69.02	4.44	4.04	0.20	1.61	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	50.04	2.37	2.37	1.30	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.02	2.23	1.67	0.28	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	42.66	2.20	1.26	0.63	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	41.40	0.54	2.15	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	44.75	2.84	2.21	0.63	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	34.50	1.51	0.97	0.86	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	38.99	1.23	2.87	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.88	1.77	1.01	0.76	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	40.82	2.53	1.27	0.99	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	37.97	0.79	0.40	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.90	2.33	1.94	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.70	0.93	1.11	0.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	38.68	1.05	1.39	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.02	1.43	0.48	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.56	1.79	1.24	0.96	0.55	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.49	1.85	0.62	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.55	3.12	0.62	0.00	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	48.49	1.83	1.46	1.46	0.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	34.89	0.66	0.66	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.32	3.51	1.17	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	42.32	1.74	1.00	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	40.25	0.00	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.01	2.42	1.35	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	40.12	0.30	0.76	0.45	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	35.77	2.59	0.52	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	40.41	2.51	1.26	0.21	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.34	1.50	1.65	0.75	0.90	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.02	2.06	2.06	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	35.18	1.88	1.51	0.00	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	32.55	1.91	1.06	0.95	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.28	1.94	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.75	1.98	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	37.29	1.86	1.12	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.39	3.70	1.11	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.72	0.99	1.48	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.64	1.10	1.51	0.27	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.74	1.29	0.96	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.65	1.83	2.43	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.09	1.12	1.40	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.62	0.71	2.13	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	34.90	0.48	0.00	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.57	1.09	1.09	0.00	0.78	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	32.23	1.79	1.43	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	47.04	5.23	3.59	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.25	1.88	1.41	0.71	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	48.76	4.21	2.60	1.61	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.97	2.56	1.54	0.26	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.52	1.79	1.19	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	39.12	1.53	0.77	0.00	3.84	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.08	2.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.93	2.96	0.85	0.00	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.72	2.11	0.70	0.00	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	54.17	3.74	4.67	0.00	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.58	0.52	1.55	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	42.82	4.76	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	43.20	2.71	1.81	0.00	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.37	1.45	2.33	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	37.81	1.35	0.90	0.00	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	66.66	2.57	2.30	0.00	2.85	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	49.30	1.54	2.57	0.00	1.03	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	36.34	2.82	1.41	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	0.67	1.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	55.01	3.57	1.02	0.00	3.06	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	39.22	1.87	1.33	0.00	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.81	2.46	2.83	0.00	1.70	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	58.90	3.07	1.23	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	56.26	7.34	1.63	0.00	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	39.36	1.87	2.08	0.00	1.46	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	35.59	0.56	1.40	0.00	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	51.52	5.15	2.06	0.00	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	37.16	2.90	1.74	0.00	1.74	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.97	1.49	2.09	0.00	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.81	2.21	0.00	0.00	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	55.14	2.47	3.89	0.35	1.77	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.79	2.95	2.58	0.00	1.11	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	34.54	2.30	1.15	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	53.73	3.84	2.30	0.00	1.15	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	47.55	1.70	3.40	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.13	2.46	2.46	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	49.26	2.26	2.26	0.00	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.93	2.15	0.72	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.81	1.49	2.24	0.00	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	46.08	4.46	4.09	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	42.21	1.29	1.72	0.00	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	38.53	4.28	3.43	0.00	2.57	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.31	0.67	0.67	0.00	2.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.69	3.02	3.02	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	35.55	1.42	4.27	0.00	0.00	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.28	2.41	1.37	0.00	1.03	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.45	1.07	1.07	0.00	2.68	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	42.42	2.69	2.69	0.00	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	45.19	1.48	0.74	0.00	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	48.84	5.81	0.00	0.00	3.49	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	49.71	2.12	4.23	0.00	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	50.82	2.00	2.40	0.00	2.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	66.15	2.18	1.45	0.00	3.63	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	62.09	3.83	3.83	0.00	2.30	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.34	3.95	2.96	0.00	1.48	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.99	5.65	1.88	0.00	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.86	3.02	3.02	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	68.04	1.80	2.25	0.00	3.15	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	3.44	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	65.47	2.23	5.34	0.00	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	71.56	5.47	5.08	0.00	3.52	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	53.44	2.64	1.98	0.00	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	78.88	4.67	4.67	0.00	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	72.20	3.50	3.94	0.00	1.75	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	59.26	4.47	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.97	1.32	4.42	0.00	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	57.09	3.86	1.54	0.00	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	55.70	0.51	1.52	0.00	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	66.33	2.88	1.92	0.00	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	53.67	5.57	1.59	0.00	3.98	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	61.98	1.22	1.22	0.00	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	4.15	2.08	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.16	3.42	3.80	0.00	1.90	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	53.19	2.07	0.52	0.00	1.55	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	48.37	1.81	1.81	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	56.41	2.54	1.58	0.00	1.58	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	55.97	1.60	3.20	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	38.50	4.02	2.30	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	56.57	3.60	4.11	0.00	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	2.83	0.71	0.00	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	47.67	6.24	2.27	0.00	2.27	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	49.92	3.74	2.50	0.00	2.08	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	39.94	2.35	1.57	0.00	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	37.58	2.92	1.25	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	47.86	3.25	1.86	0.00	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	37.47	1.34	1.34	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	48.12	4.81	0.00	0.00	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	44.85	3.23	2.02	0.00	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	3.67	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	42.68	3.56	3.56	0.00	3.56	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	58.13	2.85	2.28	0.00	1.14	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	45.25	2.30	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	40.49	4.38	5.47	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	48.55	1.34	1.34	0.00	0.45	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	47.05	3.12	2.86	0.00	2.08	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.12	4.64	3.32	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	51.97	2.08	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	56.75	4.79	3.19	28.49	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	40.19	2.02	1.10	20.19	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	55.32	1.70	2.10	14.81	0.92	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	0.53	0.00	7.43	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	36.92	1.58	1.74	0.16	0.48	0.32
Mallassez-derived cells, donor3	11930-125I4	35.86	1.25	2.22	0.14	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	80.61	3.19	3.49	0.90	2.09	0.30
Mammary Epithelial Cell, donor2	11350-117G9	53.57	2.61	2.32	0.29	2.03	0.29
Mammary Epithelial Cell, donor3	11422-118F9	39.91	1.75	3.74	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	301.00	8.81	7.46	28.47	2.03	0.00
Mast cell, donor1	11563-120D6	170.75	10.17	4.76	17.09	1.41	0.00
Mast cell, donor2	11565-120D8	289.45	21.69	7.43	18.72	1.78	0.59
Mast cell, donor3	11566-120D9	228.28	22.29	7.88	16.43	2.03	0.68
Mast cell, donor4	11567-120E1	297.14	21.98	11.17	14.54	2.30	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	185.41	10.31	6.99	24.06	3.88	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	136.00	5.84	6.42	30.94	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	170.94	10.32	5.97	34.88	1.72	0.34
Mast cell, expanded, donor8	11941-126A6	257.41	10.21	5.86	11.38	1.67	0.84
Melanocyte - dark, donor1	11502-119F8	14.73	0.90	0.99	0.10	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	30.11	1.04	1.73	4.85	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	40.13	2.25	1.45	3.40	1.23	0.07
Melanocyte - light, donor1	11274-116H5	76.63	2.59	4.00	4.94	1.88	0.47
Melanocyte - light, donor2	11351-117H1	61.42	2.73	1.36	4.09	0.68	0.68
Melanocyte - light, donor3	11423-118G1	34.69	0.00	1.73	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	34.15	0.62	1.15	12.08	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	32.00	1.08	0.81	2.96	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	45.80	2.41	1.61	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	56.08	3.10	5.21	0.50	2.73	0.87
Meningeal Cells, donor2	11573-120E7	57.66	7.48	3.08	0.00	2.64	1.32
Meningeal Cells, donor3	11654-122E7	19.72	0.98	1.87	0.57	1.55	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.96	1.43	1.71	0.00	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	95.30	4.23	2.82	1.61	1.41	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	35.48	0.00	0.00	5.26	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	2.87	1.44	16.50	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	50.61	3.81	3.39	1.91	2.33	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	57.30	1.01	2.51	3.02	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.74	2.86	2.20	0.00	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	47.49	2.92	2.19	0.00	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	29.67	2.05	2.05	0.20	1.02	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.38	1.39	1.80	0.00	1.25	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	77.69	1.49	1.12	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.60	2.63	1.97	0.00	1.32	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	57.57	2.97	1.78	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	32.02	0.64	1.92	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.98	0.35	0.35	7.80	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	42.84	2.50	1.56	0.00	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	1.45	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	49.59	0.80	2.39	2.39	2.12	0.27
Mesothelial Cells, donor2	12156-128G5	32.53	2.50	3.00	2.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	45.67	2.53	1.52	0.94	1.37	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	1.35	2.70	8.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	63.29	2.96	2.46	18.72	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	60.36	3.83	1.77	23.85	1.18	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	79.51	3.46	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.04	2.48	1.55	13.33	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.89	1.04	1.66	19.29	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	71.80	2.32	0.00	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	56.81	2.25	1.50	12.01	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	63.77	1.86	1.86	20.02	2.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	214.13	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.69	1.63	1.83	14.83	0.81	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	48.31	2.38	1.19	15.84	1.58	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	0.00	0.88	20.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.02	1.90	1.90	30.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	85.53	2.63	2.63	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	47.11	2.55	1.91	22.50	1.06	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	47.88	3.68	0.92	5.52	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	56.03	2.98	2.68	12.82	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	50.30	1.68	1.68	1.68	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	44.16	2.76	1.76	16.81	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	43.49	1.90	1.66	12.60	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	74.09	3.32	0.55	2.76	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	55.95	2.53	1.38	19.80	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.42	2.10	1.68	17.88	1.26	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	71.54	5.10	2.04	16.51	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	54.06	2.15	1.07	17.16	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	57.13	3.78	1.56	10.89	1.11	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	134.14	0.00	10.32	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	68.55	3.50	2.85	12.70	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	68.95	2.53	2.03	6.08	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	130.90	3.31	6.63	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	86.97	4.35	2.72	6.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	65.87	5.88	3.53	12.06	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	87.23	4.36	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	47.57	4.32	1.44	17.30	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	69.24	2.80	2.00	15.61	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	60.33	0.00	1.37	2.74	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	51.06	2.50	1.50	7.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	26.95	107.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	45.11	4.82	2.19	7.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	77.26	4.41	3.31	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	73.64	3.20	1.92	0.64	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	53.80	0.50	1.24	9.92	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	40.36	3.48	0.70	5.57	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	38.63	1.37	0.34	5.13	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	60.83	1.31	2.63	3.06	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	61.43	1.07	2.84	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.85	2.24	2.81	7.86	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	69.41	5.40	2.91	3.33	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	71.10	1.17	1.17	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	56.41	2.71	1.81	5.43	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	53.84	5.84	0.83	7.93	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	80.35	2.77	1.85	3.69	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.34	2.28	0.00	4.55	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	61.91	3.18	1.24	2.35	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	48.98	3.11	1.04	8.81	1.55	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	72.07	3.43	2.57	3.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	82.57	3.18	1.91	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	65.39	1.87	1.33	3.20	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	72.74	6.29	3.29	10.78	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	62.72	1.41	1.27	1.70	0.71	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	53.83	2.55	1.91	6.37	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	74.52	4.86	2.43	4.20	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	79.25	3.41	1.14	1.14	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	68.75	2.84	1.42	7.67	1.14	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	56.04	3.69	2.21	10.08	2.21	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	72.34	4.56	1.30	1.30	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	74.39	3.82	1.18	5.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	77.56	5.77	4.04	8.94	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	74.19	1.65	3.71	7.01	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	85.76	3.87	1.79	4.17	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	0.00	0.00	37.67	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	0.00	0.00	12.48	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.76	1.64	1.64	25.96	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	42.08	2.10	4.21	18.94	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.57	1.58	2.57	27.68	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	3.73	1.86	40.05	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	59.71	1.50	1.13	45.81	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	37.29	1.07	1.33	14.12	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	36.64	1.58	1.81	24.88	0.11	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	33.15	0.00	0.74	22.10	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	56.80	1.83	1.83	26.38	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	0.00	0.00	20.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	15.50	1.07	0.53	37.95	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	27.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	3.03	0.00	29.29	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.18	0.42	0.42	15.18	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	62.65	1.36	0.00	34.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.08	0.00	0.00	36.88	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	15.39	0.81	0.81	26.72	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	1.51	0.00	18.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	319.77	22.84	5.71	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	199.01	26.10	13.05	39.15	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	12.55	37.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	49.55	2.59	2.80	0.00	1.94	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	47.56	3.66	2.61	0.00	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.71	1.33	3.34	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	77.63	1.67	1.67	0.00	3.34	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	101.35	1.90	2.28	0.00	3.23	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	92.56	3.19	3.19	0.00	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.12	1.36	0.68	0.68	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.13	1.67	2.93	0.00	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	69.27	2.09	2.56	0.23	0.70	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	43.78	2.16	2.16	0.00	2.43	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	71.69	3.36	3.36	0.00	2.52	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	1.49	0.00	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	48.72	1.62	2.71	0.00	2.44	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	38.31	2.27	3.17	0.00	2.27	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	34.29	1.96	1.31	0.00	1.31	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	63.79	2.55	2.19	0.00	1.64	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	47.74	3.18	4.77	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	41.42	1.80	1.20	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	80.73	1.64	0.98	0.00	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	50.58	2.11	3.09	0.00	2.28	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	69.67	2.82	2.29	0.00	1.76	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	40.08	1.41	0.70	0.00	2.81	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	55.62	2.30	0.46	0.46	2.76	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	53.66	2.57	1.93	0.32	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	72.77	1.72	1.38	0.34	2.07	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	121.37	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	73.74	2.67	2.90	0.00	2.23	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	61.82	2.12	4.66	0.00	1.27	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	59.34	2.85	2.37	0.47	2.14	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	50.65	2.15	2.15	0.00	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	83.64	3.00	5.00	0.00	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	64.02	2.71	4.51	0.00	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	47.22	1.19	2.78	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	44.57	0.93	1.86	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	84.38	3.41	1.89	0.00	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	47.58	2.93	2.28	0.00	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	52.73	1.31	1.31	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	74.63	3.17	3.62	0.00	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	2.65	2.65	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	41.22	4.65	4.65	0.00	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	55.56	2.98	1.98	0.00	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	67.38	3.83	2.68	0.00	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	76.82	3.33	2.42	0.00	3.33	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	67.19	2.87	2.65	0.00	0.66	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.98	3.39	3.39	0.00	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	64.02	2.44	2.44	0.00	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	93.79	2.52	4.09	0.00	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.62	3.93	1.21	0.00	1.21	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	0.79	3.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	100.89	0.00	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	35.41	1.61	1.74	2.24	1.49	0.37
Myoblast, donor2	11322-117D8	48.91	3.84	0.96	0.19	2.30	0.19
Myoblast, donor3	11398-118D3	50.28	4.71	3.53	0.00	2.86	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	72.67	3.50	4.52	0.00	1.02	0.58
Natural Killer Cells, donor1	11230-116C6	231.87	8.00	4.00	1.23	1.54	1.85
Natural Killer Cells, donor2	11311-117C6	202.95	8.14	2.11	0.30	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	213.32	4.97	4.23	1.10	0.55	0.55
Neural stem cells, donor1	11275-116H6	121.95	2.54	6.90	0.36	2.90	1.45
Neural stem cells, donor2	11352-117H2	177.16	13.48	5.78	0.00	3.85	0.00
Neurons, donor1	11494-119E9	51.21	9.10	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	47.78	2.64	3.96	0.00	1.32	0.22
Neurons, donor3	11655-122E8	60.02	1.64	3.29	0.00	3.29	0.00
Neutrophils, donor1	11233-116C9	500.19	31.55	12.99	10.21	4.64	0.00
Neutrophils, donor2	11314-117C9	275.39	23.19	8.70	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	639.55	34.82	14.66	16.49	5.50	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.50	2.14	2.37	0.00	1.07	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	1.63	1.30	0.00	1.30	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	24.67	3.01	1.80	0.00	1.20	0.80
Olfactory epithelial cells, donor1	11933-125I7	60.43	2.48	2.06	0.00	1.79	0.55
Olfactory epithelial cells, donor2	11934-125I8	51.38	3.04	1.45	0.00	1.45	0.29
Olfactory epithelial cells, donor3	11935-125I9	47.45	1.48	2.04	0.00	1.48	0.34
Olfactory epithelial cells, donor4	11936-126A1	81.52	3.99	1.75	0.00	1.36	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	38.52	2.41	1.81	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	30.42	3.40	2.34	0.21	1.49	0.00
Osteoblast - differentiated, donor2	11353-117H3	18.29	2.29	3.43	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	33.52	1.24	1.86	3.10	0.62	0.00
Osteoblast, donor1	11277-116H8	40.06	3.32	2.93	0.00	0.98	0.59
Osteoblast, donor2	11354-117H4	61.10	3.51	3.51	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	54.39	1.96	3.73	0.00	1.96	0.18
Pancreatic stromal cells, donor1	11249-116E7	50.37	3.62	2.70	0.42	1.43	0.25
Pericytes, donor1	11491-119E6	24.37	1.67	1.22	0.00	1.67	0.67
Pericytes, donor2	11571-120E5	19.01	1.58	1.81	0.00	0.91	0.00
Pericytes, donor3	11652-122E5	35.81	1.22	1.63	2.85	0.81	0.00
Perineurial Cells, donor1	11499-119F5	44.19	2.94	3.28	0.00	2.15	0.90
Perineurial Cells, donor2	11579-120F4	38.00	2.58	1.10	5.43	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	209.09	7.01	4.78	21.99	1.27	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	138.84	5.14	2.20	12.00	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	153.49	5.82	2.98	8.54	1.16	0.52
Placental Epithelial Cells, donor1	11278-116H9	36.59	3.35	4.07	19.61	2.63	0.48
Placental Epithelial Cells, donor2	11355-117H5	25.50	1.11	1.11	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	34.55	1.77	2.16	3.73	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	0.00	0.32	5.06	1.90	0.00
Preadipocyte - breast, donor1	11467-119B9	47.83	2.44	2.25	2.06	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	167.21	12.27	10.18	2.35	4.96	1.31
Preadipocyte - breast, donor2	11328-117E5	47.06	3.38	2.25	2.93	2.48	0.23
Preadipocyte - omental, donor1	11468-119C1	61.59	3.41	3.09	6.39	2.24	0.32
Preadipocyte - omental, donor2	11329-117E6	70.27	5.67	3.06	6.11	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	53.86	2.29	4.01	2.86	2.72	0.29
Preadipocyte - perirenal, donor1	11469-119C2	33.47	0.98	0.98	4.92	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	58.97	3.69	2.15	4.91	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	37.54	0.71	1.59	3.01	0.53	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	27.42	1.02	1.36	1.53	1.02	0.34
Preadipocyte - visceral, donor1	11280-116I2	53.09	1.49	2.33	3.35	1.68	0.47
Preadipocyte - visceral, donor2	11357-117H7	40.04	1.84	0.46	19.33	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	27.79	0.52	1.99	3.66	1.36	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	66.07	2.72	3.47	1.36	1.21	0.30
Prostate Epithelial Cells, donor2	11331-117E8	29.11	2.98	2.71	0.00	1.35	0.27
Prostate Epithelial Cells, donor3	11404-118D9	40.85	2.33	2.94	0.06	2.76	0.06
Prostate Stromal Cells, donor1	11254-116F3	62.65	3.99	2.51	0.46	1.25	0.11
Prostate Stromal Cells, donor2	11332-117E9	61.68	3.59	3.41	0.18	1.43	0.00
Prostate Stromal Cells, donor3	11405-118E1	72.58	4.17	4.07	0.10	2.50	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	43.43	1.46	2.19	6.20	2.19	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.33	1.18	2.77	1.39	1.39	0.21
Renal Epithelial Cells, donor1	11517-119H5	44.64	3.55	1.52	6.09	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	1.42	1.42	5.69	1.42	1.42
Renal Epithelial Cells, donor3	11678-122H4	27.31	1.48	1.91	3.28	1.38	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.30	1.36	0.68	6.13	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	44.47	1.75	1.62	14.69	1.62	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	62.16	2.89	0.89	4.66	1.33	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	3.33	1.33	3.99	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	45.78	2.42	1.98	1.54	1.32	0.44
Renal Mesangial Cells, donor2	11598-120H5	37.62	1.88	2.51	3.76	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	21.36	0.28	0.83	3.61	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	55.56	3.22	4.29	3.49	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.89	0.00	0.42	1.69	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	31.43	1.74	2.12	7.71	1.35	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.96	1.56	1.30	0.26	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	54.01	3.41	1.99	0.00	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.57	1.25	1.00	0.50	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	115.06	5.61	5.21	31.00	1.34	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	150.09	9.83	5.36	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	99.62	2.75	3.30	0.00	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	167.06	4.64	5.80	0.00	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	167.21	9.49	11.44	0.00	7.02	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	128.00	7.25	7.45	0.00	3.77	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	149.02	7.81	9.15	0.00	4.68	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	115.48	8.43	6.95	0.00	4.09	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	116.66	4.66	7.46	0.00	3.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	157.17	6.01	8.55	0.00	3.24	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	156.62	11.64	9.45	0.00	5.34	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	125.25	5.29	7.87	0.00	3.33	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	158.76	11.65	13.44	0.00	5.38	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	140.30	9.90	13.48	0.00	3.44	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	106.13	5.37	5.69	0.00	3.97	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	145.82	8.41	8.19	0.00	4.65	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	171.68	12.24	8.99	0.00	5.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	123.81	4.56	7.64	0.00	5.78	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	166.67	9.21	10.15	0.00	4.70	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	156.99	12.61	10.22	0.00	4.51	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	148.74	7.20	7.40	0.00	4.96	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	152.58	7.26	8.59	0.00	5.16	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	149.62	12.92	10.15	0.00	3.95	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	140.99	6.17	7.29	0.00	3.64	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	160.64	8.37	7.69	0.00	6.15	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	148.05	8.02	9.48	0.00	3.28	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	138.57	5.89	7.60	0.00	4.54	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	144.13	7.25	8.06	0.00	5.10	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	156.38	10.14	8.49	0.00	3.54	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	134.52	8.33	7.74	0.00	3.97	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	160.18	7.25	9.12	0.00	4.21	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	131.88	10.37	8.09	0.00	2.70	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	142.02	5.31	7.74	0.00	4.42	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	167.53	6.27	7.10	0.00	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	134.05	9.69	10.50	0.00	5.92	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	156.84	6.30	7.83	0.00	4.43	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	162.14	5.59	10.99	0.00	4.82	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	146.66	11.69	11.18	0.00	3.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	140.46	7.68	7.68	0.00	4.12	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	151.86	8.70	10.01	0.00	4.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	148.96	8.86	7.67	0.00	2.90	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	120.14	8.73	7.10	0.00	4.44	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	154.87	9.33	8.26	0.00	4.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	126.79	8.71	8.85	0.00	4.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	103.34	5.95	3.81	0.00	2.62	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	185.01	7.46	8.26	0.00	4.03	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	101.80	9.61	8.19	0.00	3.48	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	111.45	4.89	6.64	0.00	2.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	117.26	6.95	3.32	0.00	2.42	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	116.02	7.83	8.32	0.00	2.20	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	304.06	16.45	19.07	0.15	5.82	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	137.50	9.73	5.48	0.00	1.83	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	109.41	8.14	6.93	0.00	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	134.58	6.79	7.24	0.00	1.81	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	156.06	11.38	6.29	0.00	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	126.34	10.63	8.50	0.00	2.72	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	146.64	8.11	6.40	0.00	4.48	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	164.07	10.22	7.81	0.00	3.00	0.00
Schwann Cells, donor1	11498-119F4	29.90	2.07	3.01	0.19	2.63	0.56
Schwann Cells, donor2	11578-120F3	37.43	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	32.64	2.19	1.75	0.66	1.53	0.44
Sebocyte, donor1	11220-116B5	90.38	3.83	2.74	2.19	1.10	0.00
Sebocyte, donor2	11301-117B5	47.33	0.46	0.92	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	38.13	1.86	0.82	0.41	1.24	0.21
Sertoli Cells, donor1	11255-116F4	87.80	0.00	3.31	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	50.84	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	40.47	2.46	3.52	0.00	2.46	0.09
Skeletal Muscle Cells, donor2	11358-117H8	31.81	2.17	2.17	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	56.01	6.69	1.67	0.00	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	37.23	1.57	2.51	0.00	1.26	0.16
Skeletal Muscle Cells, donor5	11455-119A6	35.97	1.49	1.78	0.00	2.08	0.59
Skeletal Muscle Cells, donor6	11459-119B1	49.40	3.08	3.69	0.00	2.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.89	4.03	3.15	0.13	1.64	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.81	3.14	2.28	0.00	1.28	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	48.12	1.79	3.27	0.60	1.98	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.83	2.61	2.86	0.00	1.77	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	5.07	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	31.79	2.20	1.38	0.00	1.38	0.14
Skin - palm, donor1	10286-104F7	177.28	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.96	0.43	1.73	0.43	1.01	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	411.40	2.45	7.36	0.00	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.43	1.30	0.78	0.26	1.30	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	46.98	3.06	3.48	0.97	0.97	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	55.70	2.25	2.81	0.56	1.55	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	220.96	16.28	17.13	0.00	6.55	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	52.39	2.40	2.70	0.30	2.10	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.95	0.93	0.62	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	175.86	13.12	10.67	0.22	5.11	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	60.55	2.94	2.35	0.00	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	70.50	5.97	6.63	1.55	1.10	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	42.92	2.76	2.76	2.36	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	51.76	3.09	7.73	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	106.08	5.00	4.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.85	1.60	2.26	0.13	1.73	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.03	1.55	2.22	0.22	0.89	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	36.62	1.92	2.05	0.13	1.15	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	1.63	4.56	0.00	3.26	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.68	1.77	2.66	0.89	2.66	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	49.69	1.99	2.42	1.28	2.42	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.83	1.63	1.30	0.00	0.65	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	52.97	3.65	1.83	0.30	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.84	3.28	1.77	0.00	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	42.84	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.81	2.86	1.43	0.48	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	61.94	3.10	2.80	0.29	0.59	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	54.89	2.37	3.23	0.22	1.72	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	53.74	3.25	2.41	0.94	1.57	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	43.00	1.86	2.32	1.55	1.70	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	45.27	2.16	0.00	0.00	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.98	2.69	1.49	3.59	1.79	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.07	2.39	3.07	1.02	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	61.02	3.53	3.06	0.31	1.81	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	49.21	2.42	1.61	0.00	1.21	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.12	2.73	3.41	1.59	1.37	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	43.47	4.23	2.42	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	39.74	2.38	1.59	0.00	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.97	6.13	6.79	0.13	2.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	65.74	2.75	3.76	0.00	1.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	46.42	3.04	2.54	1.78	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.00	2.86	2.41	0.45	0.75	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	3.00	3.00	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	518.18	42.64	36.18	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	93.94	5.12	4.65	0.00	3.72	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	35.85	3.53	0.50	0.00	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	40.11	2.51	1.88	0.31	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	1.18	1.47	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	28.24	1.83	2.75	0.25	1.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	30.37	2.34	0.93	1.40	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	51.81	3.31	2.30	1.01	1.44	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	50.99	2.29	2.29	0.76	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	33.47	1.32	1.50	1.50	1.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.06	1.82	2.38	0.00	0.84	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.98	1.09	1.59	0.00	0.67	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	23.81	0.95	3.81	0.48	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	43.31	1.71	3.18	0.49	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.55	2.21	2.43	1.10	1.55	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	56.18	4.10	3.51	1.17	2.05	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	82.80	1.55	3.50	0.78	0.97	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.18	0.53	2.12	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	53.93	1.12	1.86	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	94.86	3.59	5.75	0.00	3.59	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	57.92	0.57	3.97	0.28	1.14	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	65.78	0.39	1.97	0.79	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	66.03	1.27	2.03	0.25	2.03	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	97.03	2.00	2.80	0.40	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	63.54	1.67	2.51	0.00	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	66.92	3.21	0.92	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	46.46	2.52	2.19	0.34	0.34	0.00
Synoviocyte, donor2	11368-117I9	29.33	2.85	1.34	1.01	1.34	0.17
Synoviocyte, donor3	11440-118H9	32.84	4.92	1.79	0.22	1.12	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	43.59	2.14	3.57	0.00	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	1.98	1.98	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	39.83	1.39	2.08	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	44.44	2.08	2.80	0.14	1.29	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	36.72	2.32	1.55	1.16	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	36.08	3.44	2.29	0.00	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	103.59	5.41	6.03	31.00	1.72	0.62
Urethra, donor2	10319-105A4	125.89	3.60	0.00	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	30.29	0.80	0.53	17.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	34.45	1.60	1.20	18.43	1.20	0.00
Urothelial Cells, donor3	11681-122H7	30.03	1.38	2.06	22.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	35.89	1.56	2.23	14.27	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	104.10	7.12	1.78	8.90	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	102.93	4.29	1.43	4.29	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	66.40	2.74	8.21	8.90	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	101.58	2.07	1.03	8.26	0.00	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	103.42	2.91	0.58	8.13	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	103.08	9.37	2.08	12.49	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	117.48	5.51	2.75	12.85	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	63.90	4.56	4.56	5.48	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	92.89	4.69	5.67	0.00	3.70	0.74
Wilms' tumor cell line:HFWT	10597-108E3	52.80	0.88	7.04	0.00	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	93.85	2.23	6.98	0.28	3.35	0.00
achilles tendon, donor2	10292-104G4	134.32	2.07	4.13	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	99.43	6.12	6.88	0.00	2.80	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	108.43	4.88	3.71	0.00	1.63	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	167.85	9.38	9.50	0.00	3.56	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	120.82	6.80	6.80	0.00	1.36	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	102.88	3.65	7.03	0.00	1.41	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	75.92	2.54	4.65	0.21	1.90	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	103.71	4.36	4.08	0.27	1.91	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	148.50	4.41	4.41	3.97	2.64	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	108.62	4.90	2.04	0.41	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	205.02	10.48	7.38	3.88	1.94	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	66.42	3.86	4.60	24.10	2.02	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	175.52	7.80	7.80	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	88.77	3.25	2.56	0.00	1.39	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	73.79	3.88	3.11	0.52	2.33	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	88.26	3.51	3.51	1.17	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	73.43	2.32	5.11	8.37	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	75.67	1.65	2.47	30.84	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	61.70	2.15	2.15	15.65	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.43	3.84	4.69	20.48	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.09	5.16	5.76	24.87	1.82	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	61.14	4.09	4.57	24.07	1.93	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	59.92	1.78	1.56	48.56	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	105.40	4.67	4.67	0.33	2.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	219.27	5.57	5.57	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	144.26	5.27	4.14	6.40	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	122.55	2.62	3.49	0.00	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	318.66	5.62	5.62	1.87	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	102.91	4.71	4.47	15.07	1.65	0.47
adipose tissue, adult, pool1	10010-101C1	82.52	6.05	5.43	9.93	1.09	0.47
adipose, donor1	10184-103D4	214.04	5.86	11.14	0.00	4.10	0.00
adipose, donor2	10185-103D5	92.86	5.27	5.27	0.00	3.24	0.41
adipose, donor3	10186-103D6	137.23	7.90	6.53	0.00	4.63	0.00
adipose, donor4	10187-103D7	273.03	18.20	15.60	0.00	9.53	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	106.69	6.94	4.89	0.00	6.00	2.05
adrenal gland, adult, pool1	10081-102A9	98.22	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	62.70	4.14	7.07	0.00	3.20	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	94.33	2.50	5.72	0.00	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	70.25	6.96	3.01	47.07	3.01	0.70
amniotic membrane cells, donor2	12236-129G4	70.33	3.38	5.07	3.04	1.69	2.03
amniotic membrane cells, donor3	12237-129G5	43.31	3.54	3.83	57.15	1.77	0.29
amygdala - adult, donor10196	10167-103B5	131.62	8.30	9.49	0.00	4.74	0.00
amygdala, adult, donor10252	10151-102I7	120.44	5.47	6.08	2.84	6.69	1.22
amygdala, newborn, donor10223	10360-105E9	86.82	4.52	8.07	2.26	2.58	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	108.99	7.26	5.60	0.00	2.04	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	77.22	2.87	3.75	0.00	1.76	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	150.98	7.68	4.34	0.00	4.01	4.34
aorta, adult, pool1	10052-101G7	123.76	6.67	4.31	1.18	1.57	1.18
appendix, adult	10189-103D9	166.50	3.88	5.05	1.16	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	68.10	3.10	5.16	0.00	1.72	0.00
artery, adult	10190-103E1	115.49	2.72	5.43	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	123.28	3.04	2.46	4.06	1.30	0.14
b cell line:RPMI1788	10427-106D4	80.15	5.95	5.80	0.00	3.12	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	74.08	3.61	4.16	8.32	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	67.58	2.38	2.38	7.64	0.69	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	66.95	3.01	3.01	23.43	0.67	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	71.58	2.80	3.91	3.91	0.00	0.00
bladder, adult, pool1	10011-101C2	127.44	9.34	6.52	5.11	1.20	0.54
blood, adult, pool1	10053-101G8	70.87	0.00	0.00	11.07	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	118.18	6.85	1.71	0.86	1.71	1.71
bone marrow, adult	10192-103E3	79.63	2.02	2.02	4.72	0.67	2.02
brain, adult, donor1	10084-102B3	82.01	6.15	5.13	0.00	4.10	0.00
brain, adult, pool1	10012-101C3	76.84	6.12	3.90	0.00	4.57	0.22
brain, fetal, pool1	10085-102B4	189.67	16.03	10.69	0.00	13.36	2.67
breast carcinoma cell line:MCF7	10482-107A5	62.11	1.32	2.97	0.00	5.29	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	115.46	5.24	6.74	0.00	3.87	0.12
breast, adult, donor1	10080-102A8	77.66	3.79	2.53	3.16	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.86	3.05	3.18	1.27	0.64	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	122.76	6.80	1.86	0.00	3.71	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	102.45	4.83	2.99	0.00	0.69	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	132.18	5.81	6.54	0.00	4.12	0.48
carcinoid cell line:NCI-H1770	10703-109H1	157.04	9.40	10.34	0.00	5.64	0.94
carcinoid cell line:NCI-H727	10735-110B6	67.93	4.81	4.27	0.11	2.84	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	89.68	3.80	4.12	0.00	4.75	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	81.18	4.53	4.26	0.00	4.79	4.26
caudate nucleus - adult, donor10196	10177-103C6	133.55	1.15	3.45	2.30	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	104.91	6.36	5.35	6.86	2.68	0.00
caudate nucleus, adult, donor10258	10379-105H1	101.63	7.64	5.35	1.53	3.82	1.53
caudate nucleus, newborn, donor10223	10354-105E3	91.92	5.86	5.49	1.10	4.39	0.00
cerebellum - adult, donor10196	10173-103C2	186.45	14.57	11.65	0.00	11.65	8.74
cerebellum, adult, donor10252	10166-103B4	136.65	12.17	13.66	0.43	12.60	3.20
cerebellum, adult, pool1	10083-102B2	55.54	7.24	4.14	0.00	4.83	1.72
cerebellum, newborn, donor10223	10357-105E6	185.98	9.13	7.47	2.49	14.11	0.83
cerebral meninges, adult	10188-103D8	94.80	3.03	4.54	0.50	3.28	0.00
cerebrospinal fluid, donor2	10294-104G6	98.67	5.12	4.39	1.46	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	119.48	9.49	9.92	0.00	3.88	0.43
cervical cancer cell line:ME-180	10553-107I4	61.48	4.47	3.15	0.66	1.16	0.00
cervix, adult, pool1	10013-101C4	115.70	5.77	5.56	8.92	1.78	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	62.01	2.79	3.20	0.14	1.39	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	87.52	2.61	3.92	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	103.27	5.10	4.60	0.00	2.73	0.12
choriocarcinoma cell line:SCH	10785-110H2	58.65	2.34	2.34	0.00	0.74	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	119.54	4.27	6.40	0.24	1.90	0.00
chorionic membrane cells, donor1	12238-129G6	55.84	5.41	1.71	13.11	1.14	1.14
chorionic membrane cells, donor2	12239-129G7	93.07	5.57	3.18	1.79	1.89	0.10
chorionic membrane cells, donor3	12240-129G8	68.69	2.20	2.20	0.00	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	48.47	4.04	3.03	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	72.61	3.27	2.50	0.96	1.34	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	224.49	10.56	10.98	10.77	3.59	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	165.89	11.81	5.91	1.28	2.05	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	176.33	12.82	9.19	2.42	2.42	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	171.03	13.23	8.76	2.04	1.63	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	187.27	16.78	12.66	4.42	4.42	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	281.21	14.86	12.25	20.07	6.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	84.58	5.03	4.11	0.00	3.43	1.37
clear cell carcinoma cell line:TEN	10636-108I6	74.95	8.33	4.68	0.00	1.39	1.74
colon carcinoma cell line:CACO-2	10513-107D9	148.26	8.60	4.58	0.55	1.28	0.18
colon carcinoma cell line:COLO-320	10420-106C6	134.93	5.32	4.94	0.00	1.52	0.00
colon, adult, donor1	10082-102B1	103.53	4.76	2.38	0.00	2.38	2.38
colon, adult, pool1	10014-101C5	103.17	6.46	6.70	1.29	2.47	0.59
colon, fetal, donor1	10070-101I7	68.60	3.09	2.47	0.62	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	916.70	50.42	36.67	0.00	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	299.15	14.45	13.60	0.00	2.97	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	95.99	4.38	3.77	0.00	0.91	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	94.76	6.35	5.50	0.00	0.28	0.28
corpus callosum, adult, pool1	10042-101F6	151.25	10.17	7.96	0.00	4.20	0.11
cruciate ligament, donor2	10295-104G7	150.75	5.67	4.86	5.67	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	105.14	3.21	2.41	0.00	0.80	0.00
diencephalon, adult	10193-103E4	63.84	3.12	2.40	0.24	2.64	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	61.77	3.67	2.53	0.00	1.15	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	116.17	6.15	6.15	1.54	3.08	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	98.21	7.94	5.54	0.24	2.41	0.96
ductus deferens, adult	10196-103E7	138.54	7.97	6.48	1.50	2.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	95.06	5.76	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	101.52	7.36	2.94	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	134.53	10.98	5.12	3.06	3.72	1.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	193.20	9.55	8.88	0.00	1.33	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.95	4.30	4.44	0.00	2.87	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	76.46	3.70	3.08	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	80.82	3.63	5.15	0.61	1.51	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	73.17	2.47	2.78	0.93	1.23	0.31
embryonic pancreas cell line:2C6	10603-108E9	93.26	2.63	6.57	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	119.66	3.02	4.69	3.69	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	100.95	7.61	5.98	0.54	3.81	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	40.52	2.25	2.25	0.00	1.45	0.32
epidermoid carcinoma cell line:A431	10426-106D3	93.04	4.34	3.78	0.11	2.78	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	87.22	4.95	4.62	0.00	1.87	0.22
epididymis, adult	10197-103E8	107.80	4.40	2.72	1.05	3.56	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	83.38	7.45	4.97	0.00	3.02	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	64.10	3.15	5.90	0.00	1.97	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	82.17	5.50	3.67	0.00	2.36	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	80.21	5.61	4.23	0.00	2.17	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	69.57	4.71	3.58	0.11	2.02	0.34
esophagus, adult, pool1	10015-101C6	71.78	4.46	3.93	6.80	1.81	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	176.08	10.27	10.65	0.00	7.26	5.64
eye - muscle inferior rectus, donor1	10272-104E2	185.92	0.00	7.24	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	140.98	8.42	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	129.47	5.95	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	137.58	5.73	5.73	1.15	2.29	1.15
eye - vitreous humor, donor1	10268-104D7	129.71	1.46	2.91	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	53.39	2.29	4.07	0.76	1.78	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	79.76	3.46	3.21	0.51	1.54	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	120.13	6.41	5.46	0.24	4.51	0.95
frontal lobe, adult, pool1	10040-101F4	120.19	9.19	7.51	0.38	6.19	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	128.81	5.10	6.91	0.00	3.90	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	101.59	5.03	6.22	17.01	2.56	0.00
gall bladder, adult	10198-103E9	112.51	6.04	5.79	3.14	2.17	1.93
gamma delta positive T cells, donor1	11937-126A2	142.80	3.22	2.15	0.00	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	126.24	3.73	3.36	0.00	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	97.16	4.44	6.34	1.27	4.01	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	110.63	8.51	7.74	0.58	2.71	0.77
gastric cancer cell line:AZ521	10549-107H9	103.29	7.71	6.72	0.00	2.62	1.31
gastric cancer cell line:GSS	10560-108A2	79.62	5.49	6.41	0.00	5.49	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	140.04	7.31	5.94	0.23	3.20	0.69
giant cell carcinoma cell line:LU65	10487-107B1	61.27	6.20	6.54	3.10	2.75	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	123.44	6.02	9.66	12.74	3.92	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	74.58	2.00	2.99	0.00	2.99	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	64.81	3.48	4.54	6.65	2.22	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.22	5.34	4.21	7.86	2.53	0.84
glioblastoma cell line:T98G	10485-107A8	118.10	4.64	5.19	0.00	1.55	0.33
glioma cell line:GI-1	10413-106B8	57.11	3.81	1.76	1.46	2.64	2.64
globus pallidus - adult, donor10196	10175-103C4	174.21	10.93	7.29	0.73	4.37	1.46
globus pallidus, adult, donor10252	10161-103A8	136.69	10.01	5.86	0.24	3.42	0.98
globus pallidus, adult, donor10258	10367-105F7	120.49	5.48	2.74	1.37	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	95.93	4.80	5.33	2.13	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	633.81	22.02	36.71	0.00	7.34	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	10.45	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	113.28	3.20	0.96	0.00	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	140.95	2.30	3.21	0.00	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	119.35	3.66	5.94	0.00	2.29	1.37
hIPS +CCl2, biol_rep3	14385-156C2	161.67	3.86	6.44	0.00	2.58	0.00
hIPS, biol_rep1	14380-156B6	181.10	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	176.27	2.74	4.80	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	119.17	4.41	6.62	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	73.85	5.75	4.02	0.00	3.16	0.29
heart - mitral valve, adult	10205-103F7	101.05	5.98	4.19	17.64	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	112.17	4.45	2.61	1.57	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	110.74	4.16	4.16	15.82	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	87.95	4.08	2.86	0.61	1.43	1.43
heart, adult, diseased, donor1	10051-101G6	137.97	2.55	3.41	1.28	1.70	0.00
heart, adult, pool1	10016-101C7	82.33	2.30	4.37	2.53	0.69	0.46
heart, fetal, pool1	10046-101G1	201.15	10.58	8.11	3.59	2.16	2.77
hepatic mesenchymal tumor cell line:LI90	10778-110G4	104.28	4.01	4.01	0.62	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	136.76	3.57	5.95	0.00	3.57	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	82.65	3.65	2.87	0.00	1.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	78.29	4.37	3.03	0.00	1.21	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	86.70	4.95	3.33	0.00	1.82	0.30
hepatoma cell line:Li-7	10484-107A7	96.09	7.67	5.12	4.56	1.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	108.74	3.62	6.53	0.00	1.71	1.01
hippocampus - adult, donor10196	10169-103B7	141.00	6.62	4.73	0.95	10.41	1.89
hippocampus, adult, donor10252	10153-102I9	113.48	9.18	6.53	0.20	3.27	0.41
hippocampus, adult, donor10258	10374-105G5	135.94	3.98	2.99	0.50	1.99	1.00
hippocampus, newborn, donor10223	10363-105F3	83.54	2.47	4.23	0.35	2.11	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	164.18	3.05	5.49	0.00	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	105.05	3.93	4.52	0.00	2.55	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	124.66	3.55	4.32	0.00	2.54	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	128.56	2.82	6.20	0.00	4.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	102.77	3.87	3.61	0.00	2.07	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	123.75	4.18	6.07	0.00	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	153.28	5.84	14.01	0.00	5.26	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	118.05	9.48	8.19	0.00	3.66	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	144.72	6.26	11.68	0.00	3.34	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	62.28	4.50	4.97	0.00	0.95	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.43	3.38	3.05	0.00	1.93	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	85.51	5.39	5.39	0.00	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	117.68	3.13	3.91	0.00	2.50	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	111.03	3.44	3.93	0.00	1.97	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	107.35	0.00	3.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	148.53	9.74	6.49	0.00	3.25	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	145.21	6.11	7.41	0.00	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	201.40	3.00	4.50	0.00	3.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	78.75	6.03	7.91	0.00	5.09	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	75.03	6.82	9.55	0.00	2.27	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	95.22	3.13	5.01	0.00	4.39	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	62.38	2.29	3.92	0.16	3.10	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.71	2.61	5.23	0.00	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	82.80	2.39	5.08	0.00	3.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	98.10	2.22	3.51	0.00	2.03	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	105.27	4.28	4.28	0.00	2.28	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	135.15	2.45	3.27	0.00	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	114.78	8.10	4.93	0.00	1.76	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	97.56	5.38	2.53	0.00	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	112.57	3.33	8.78	0.00	2.12	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	103.42	5.17	5.69	0.00	3.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	87.01	5.98	4.65	0.00	5.98	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	107.74	3.59	4.62	0.00	3.33	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.52	4.09	5.37	0.00	3.07	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	93.14	5.30	6.06	0.00	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	71.24	3.02	2.02	0.34	2.02	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	107.95	3.14	4.11	0.00	2.42	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	107.40	2.23	2.67	0.00	3.12	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	124.39	5.85	2.93	0.00	2.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	124.39	4.28	5.50	0.00	3.36	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	201.70	3.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	130.06	3.97	3.97	0.00	4.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	106.18	12.59	12.04	0.00	3.83	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	114.36	4.70	6.15	0.00	4.34	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	93.95	7.83	6.76	0.00	3.91	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	57.28	0.00	3.58	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	86.81	4.88	7.31	0.00	2.84	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	60.61	1.62	4.58	0.00	1.89	0.54
immature langerhans cells, donor1	11904-125F5	209.94	7.51	3.63	0.24	2.18	0.48
immature langerhans cells, donor2	11905-125F6	213.08	5.54	3.17	1.58	2.38	0.00
insula, adult, pool1	10039-101F3	162.30	9.84	11.36	0.19	9.37	2.08
keratoacanthoma cell line:HKA-1	10791-110H8	58.20	1.95	2.93	0.33	1.30	0.00
kidney, adult, pool1	10017-101C8	87.31	5.11	5.41	3.70	3.80	0.40
kidney, fetal, pool1	10045-101F9	142.46	8.06	6.86	1.20	4.03	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	154.80	8.10	8.81	0.14	3.69	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	46.17	1.80	0.97	39.95	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	76.52	4.04	2.94	0.00	0.92	0.55
left atrium, adult, donor1	10079-102A7	56.12	3.27	0.00	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	60.17	2.53	1.01	4.05	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	106.71	2.46	1.92	0.00	1.92	0.27
leiomyoma cell line:10964C	10569-108B2	24.07	2.16	0.36	0.00	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	42.93	1.09	1.63	0.54	1.63	0.00
leiomyoma cell line:15425	10571-108B4	29.62	1.94	0.97	0.00	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	6.35	6.35	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	78.42	8.36	3.14	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	195.27	10.03	5.67	19.72	4.01	0.35
liposarcoma cell line:KMLS-1	10782-110G8	72.01	2.66	2.50	0.16	0.94	0.31
liposarcoma cell line:SW 872	10726-110A6	80.29	2.31	2.19	0.12	1.10	0.24
liver, adult, pool1	10018-101C9	70.01	3.24	4.21	2.27	1.78	0.32
liver, fetal, pool1	10086-102B5	73.38	2.82	3.76	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	98.14	7.73	5.40	0.15	7.00	0.87
locus coeruleus, adult, donor10252	10165-103B3	103.35	7.94	7.57	0.18	6.09	0.74
locus coeruleus, adult, donor10258	10375-105G6	84.92	3.95	4.23	0.85	5.64	0.56
locus coeruleus, newborn, donor10223	10362-105F2	73.19	5.05	1.68	1.68	3.36	0.42
lung adenocarcinoma cell line:A549	10499-107C4	64.91	5.54	3.74	51.07	1.25	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	67.56	1.38	3.45	0.00	2.76	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	83.70	3.69	3.30	0.13	1.71	0.66
lung, adult, pool1	10019-101D1	93.68	4.61	4.73	6.50	1.06	0.59
lung, fetal, donor1	10068-101I5	197.50	11.70	7.99	8.28	1.71	1.71
lung, right lower lobe, adult, donor1	10075-102A3	83.85	3.67	3.67	1.83	1.37	1.37
lymph node, adult, donor1	10077-102A5	56.33	3.79	3.31	0.47	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	76.27	2.63	5.70	0.00	1.97	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	123.76	9.36	10.72	0.00	3.17	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	141.87	2.55	1.70	48.42	2.55	0.00
mature adipocyte, donor1	12231-129F8	125.65	7.10	4.88	0.00	2.66	0.44
mature adipocyte, donor2	12232-129F9	131.57	8.72	4.77	0.42	2.49	0.42
mature adipocyte, donor3	12233-129G1	124.93	7.59	6.40	0.71	3.32	0.00
mature adipocyte, donor4	12234-129G2	97.39	8.69	4.47	0.53	2.90	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	170.59	14.53	16.44	0.00	15.49	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	117.32	2.26	6.77	0.00	6.77	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	103.91	7.72	5.70	0.18	4.23	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	107.38	7.31	6.99	0.00	6.35	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	82.74	1.71	3.84	2.13	2.56	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	103.61	5.91	5.40	0.17	6.58	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	126.49	8.70	6.79	0.64	3.61	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	136.76	1.93	5.78	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	89.37	2.51	4.31	3.23	3.23	2.15
medulla oblongata - adult, donor10196	10174-103C3	145.37	5.84	3.24	0.00	3.89	0.00
medulla oblongata, adult, donor10252	10155-103A2	93.97	7.59	5.57	0.31	3.72	1.24
medulla oblongata, adult, pool1	10038-101F2	112.16	9.39	8.24	0.16	8.16	0.65
medulla oblongata, newborn, donor10223	10361-105F1	80.89	6.25	6.94	0.69	4.17	0.69
medulloblastoma cell line:D283 Med	10838-111E1	189.09	9.30	5.54	0.00	1.55	0.22
medulloblastoma cell line:ONS-76	10759-110E3	60.40	3.06	2.57	0.00	1.59	0.37
melanoma cell line:COLO 679	10514-107E1	84.81	4.02	4.46	13.22	1.15	0.14
melanoma cell line:G-361	10465-106H6	107.77	7.60	8.69	0.00	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	60.96	5.97	4.34	44.86	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	143.63	7.05	7.05	0.00	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	155.79	7.26	8.55	0.26	6.48	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.67	4.14	3.84	1.99	2.30	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.08	2.36	1.45	4.18	1.82	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	48.04	3.31	1.24	4.56	2.07	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.96	2.11	1.26	0.00	1.83	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	32.74	2.50	1.54	0.00	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	54.83	2.78	1.39	2.08	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	49.26	4.29	2.57	4.63	1.89	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	46.47	3.68	2.30	5.41	2.42	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.21	2.92	1.59	0.93	1.46	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.75	2.16	2.03	5.54	1.76	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	59.18	3.84	2.99	5.69	1.42	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	109.35	3.95	2.31	1.32	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	59.64	4.01	3.04	0.97	0.97	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	50.62	4.19	2.09	8.38	1.40	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	41.45	3.27	2.45	6.33	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	88.07	5.75	3.95	7.55	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	42.72	2.28	0.72	1.34	0.31	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	82.31	3.19	3.65	1.37	2.51	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	46.57	2.10	2.52	2.10	2.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	59.18	2.84	3.29	2.69	1.49	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.09	3.15	2.36	1.40	1.14	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	132.17	6.63	3.68	4.05	1.47	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	113.89	4.58	6.30	5.15	3.43	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.42	2.11	4.21	0.84	4.21	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.53	0.91	1.83	2.74	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	40.16	3.33	2.81	2.81	2.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	39.79	2.88	2.09	5.24	1.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	47.45	1.85	3.08	4.31	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.30	1.65	2.12	3.53	1.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.37	3.05	2.37	3.38	2.71	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.51	1.18	1.18	2.36	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.12	1.85	1.39	3.24	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	46.44	2.02	3.17	3.46	1.15	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.60	1.12	2.68	2.90	2.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	44.71	1.20	2.40	3.36	2.16	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	65.27	1.47	0.73	1.47	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.26	2.01	1.34	2.69	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.43	1.64	1.64	2.46	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.38	2.15	0.86	3.01	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	57.42	2.73	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	0.00	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	46.12	2.27	2.92	1.95	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	4.36	0.00	4.36	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	58.64	3.20	1.60	3.20	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	48.25	4.09	0.82	4.09	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	45.87	2.33	2.33	1.17	3.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	58.76	2.10	2.10	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	40.73	2.98	0.99	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	52.18	3.56	0.59	3.56	4.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	48.74	1.22	1.22	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	3.80	3.17	1.27	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.04	1.38	1.03	1.03	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.30	1.22	0.41	1.63	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	33.37	4.77	1.59	0.79	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.12	0.59	1.18	2.36	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.72	1.56	1.25	1.25	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	4.01	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	49.56	1.38	0.69	2.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	44.53	1.98	0.49	0.49	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	47.10	0.00	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	47.70	0.64	1.91	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	32.64	0.40	0.81	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	0.00	4.36	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	43.08	1.27	0.00	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.66	1.21	4.86	3.03	2.43	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	4.52	9.04	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	47.77	1.65	2.47	3.29	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.21	3.37	1.79	3.97	1.59	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.37	2.60	2.92	2.27	2.27	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	43.80	0.00	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	118.38	0.77	7.74	7.74	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	97.33	5.43	9.92	28.35	1.42	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	117.23	8.34	4.87	1.85	2.78	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	105.42	3.08	1.75	2.57	1.13	0.21
mesothelioma cell line:Mero-25	10850-111F4	56.51	1.82	2.95	0.00	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	106.59	4.40	5.13	0.24	1.96	1.47
mesothelioma cell line:Mero-48a	10852-111F6	62.89	2.21	2.21	0.00	2.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	88.57	3.94	2.10	0.79	1.31	0.00
mesothelioma cell line:Mero-83	10854-111F8	65.53	2.89	2.89	0.00	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	55.36	1.26	1.52	0.00	0.51	0.51
mesothelioma cell line:Mero-95	10856-111G1	55.49	0.62	3.11	0.00	1.45	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	61.79	2.48	0.66	36.44	1.16	0.50
mesothelioma cell line:NCI-H226	10846-111E9	55.02	1.27	2.35	0.54	1.45	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	85.07	3.76	3.25	1.02	1.54	0.68
mesothelioma cell line:NCI-H28	10845-111E8	11.20	0.76	0.76	0.00	0.25	0.25
mesothelioma cell line:No36	10857-111G2	44.69	1.63	2.28	64.91	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	100.25	4.06	3.52	2.44	1.08	1.08
migratory langerhans cells, donor1	11901-125F2	129.36	4.03	2.49	2.11	1.15	0.58
migratory langerhans cells, donor2	11902-125F3	173.53	6.59	8.55	1.22	1.34	0.24
migratory langerhans cells, donor3	11903-125F4	180.20	6.82	5.92	0.36	1.44	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	84.23	3.59	1.63	0.33	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	73.75	2.54	1.06	0.00	0.85	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	77.86	2.76	3.92	29.49	1.61	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	62.04	1.52	2.09	0.00	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	84.45	5.73	7.21	2.96	2.40	2.03
myeloma cell line:PCM6	10474-106I6	39.93	2.77	2.77	0.00	0.99	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	74.57	0.51	1.01	1.52	2.03	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	77.67	3.53	2.94	16.87	2.16	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	43.90	5.13	4.35	1.89	2.23	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	42.51	4.63	5.29	1.84	2.79	0.07
nasal epithelial cells, donor2	12227-129F4	109.29	7.18	11.04	1.10	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	117.10	5.75	4.60	0.00	1.84	0.23
neuroblastoma cell line:NB-1	10539-107G8	86.81	6.17	7.48	0.00	4.30	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	130.75	6.33	7.38	0.00	2.53	0.21
neuroblastoma cell line:NH-12	10555-107I6	94.67	5.59	4.66	0.00	0.93	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	105.57	5.46	4.74	0.00	3.32	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	83.78	3.96	2.69	0.63	2.38	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	115.32	3.42	4.03	0.00	1.81	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	153.86	2.54	5.09	0.00	3.81	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	77.45	3.99	3.19	0.80	1.33	0.53
neutrophil PMN, donor1	12133-128D9	446.24	44.62	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	13.28	0.00	146.09	0.00	0.00
neutrophil PMN, donor3	12141-128E8	151.53	9.47	0.00	170.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	237.45	7.95	4.74	0.00	1.01	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.82	2.40	3.20	0.00	4.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	77.91	3.53	1.92	0.00	1.92	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.41	4.99	1.84	0.26	1.84	0.26
nucleus accumbens, adult, pool1	10037-101F1	125.14	9.56	8.34	1.59	5.91	0.66
occipital cortex - adult, donor10196	10172-103C1	135.99	6.18	6.18	0.00	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	141.96	10.73	5.64	0.00	5.90	1.34
occipital cortex, newborn, donor10223	10355-105E4	74.97	4.37	6.55	1.46	3.64	1.82
occipital lobe, adult, donor1	10076-102A4	89.74	6.30	5.77	0.00	6.82	0.26
occipital lobe, fetal, donor1	10073-102A1	172.93	21.03	13.30	0.43	7.29	0.43
occipital pole, adult, pool1	10036-101E9	112.98	9.15	9.15	0.00	8.04	0.63
olfactory region, adult	10195-103E6	89.03	6.50	2.67	0.19	3.63	0.76
optic nerve, donor1	10277-104E7	152.08	2.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	51.49	2.73	5.01	0.00	2.28	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	81.88	6.32	4.81	2.61	2.34	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	44.70	3.05	1.35	0.34	1.19	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	80.86	3.35	2.19	0.23	0.58	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	92.01	3.82	5.00	0.59	2.94	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	190.60	2.80	7.47	0.00	2.80	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	107.51	7.21	4.88	0.00	3.61	0.64
ovary, adult, pool1	10020-101D2	94.60	6.81	5.85	0.96	1.48	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	78.09	5.32	5.68	0.55	2.02	1.28
pancreas, adult, donor1	10049-101G4	63.96	4.70	4.70	0.00	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	85.54	3.07	1.96	0.00	1.40	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	50.25	3.58	4.43	4.77	1.36	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	106.80	3.81	5.13	18.71	1.82	0.33
paracentral gyrus, adult, pool1	10035-101E8	111.11	9.98	8.88	0.37	6.68	0.46
parietal cortex, adult, donor10258	10373-105G4	116.71	4.40	6.61	0.73	4.40	0.73
parietal lobe - adult, donor10196	10171-103B9	110.98	5.64	8.46	0.00	7.52	0.94
parietal lobe, adult, donor10252	10157-103A4	131.97	7.70	6.56	0.00	5.42	1.43
parietal lobe, adult, pool1	10034-101E7	122.05	10.22	11.28	0.18	7.75	0.70
parietal lobe, fetal, donor1	10072-101I9	197.85	18.43	17.46	0.00	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	99.45	4.86	3.74	2.62	5.23	1.12
parotid gland, adult	10199-103F1	47.48	2.47	4.32	0.00	1.23	6.78
penis, adult	10200-103F2	93.46	3.76	4.83	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	83.67	5.02	7.81	0.37	2.60	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	71.39	3.35	2.62	0.00	1.02	0.29
pineal gland - adult, donor10196	10179-103C8	187.70	6.45	4.52	0.00	4.52	0.00
pineal gland, adult, donor10252	10160-103A7	164.64	13.03	8.29	0.59	6.51	0.00
pineal gland, adult, donor10258	10377-105G8	119.14	4.39	3.14	0.00	3.76	0.00
pituitary gland - adult, donor10196	10180-103C9	235.75	8.09	9.11	0.00	4.05	1.01
pituitary gland, adult, donor10252	10162-103A9	254.86	18.76	14.59	0.52	4.69	3.13
pituitary gland, adult, donor10258	10378-105G9	139.60	1.70	5.96	0.00	4.26	3.40
placenta, adult, pool1	10021-101D3	111.80	4.73	4.62	1.29	1.61	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	83.30	4.50	2.65	0.00	1.85	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	92.29	5.29	3.74	1.87	1.87	0.78
pons, adult, pool1	10033-101E6	102.42	7.40	9.55	0.09	9.38	0.60
postcentral gyrus, adult, pool1	10032-101E5	115.51	9.50	8.37	0.09	8.37	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	443.38	29.28	16.73	0.00	12.55	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	0.00	0.00	22.03	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	11.74	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	55.06	3.35	2.04	0.29	1.31	0.15
prostate cancer cell line:PC-3	10439-106E7	111.62	6.90	4.90	2.54	1.45	1.27
prostate, adult, pool1	10022-101D4	81.71	4.44	5.62	4.72	0.63	0.45
putamen, adult, donor10196	10176-103C5	119.45	6.61	4.49	2.83	4.96	0.94
putamen, adult, donor10252	10152-102I8	109.80	7.84	5.88	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	109.28	1.09	1.09	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	77.32	4.35	3.87	2.42	3.38	0.24
putamen, newborn, donor10223	10365-105F5	80.21	2.25	0.00	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	95.14	8.73	3.49	2.62	1.75	0.00
rectum, fetal, donor1	10067-101I4	123.80	9.74	5.56	1.39	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	57.24	4.88	4.66	13.36	2.76	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	86.98	9.53	6.21	21.12	3.31	0.83
retina, adult, pool1	10030-101E3	160.33	9.64	7.75	0.20	3.48	1.79
retinoblastoma cell line:Y79	10475-106I7	140.03	8.83	8.83	0.00	3.64	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	84.34	4.43	3.20	0.00	1.60	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	172.94	10.12	6.75	0.00	2.81	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	215.99	6.06	5.30	0.00	1.52	0.76
salivary acinar cells, donor1	11771-123I7	68.95	2.75	2.75	0.49	0.49	0.00
salivary acinar cells, donor2	11772-123I8	66.37	4.96	1.38	0.00	0.28	0.55
salivary acinar cells, donor3	11773-123I9	115.20	1.99	1.32	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	110.39	5.72	7.44	0.00	1.72	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.17	3.04	5.40	0.25	2.45	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	50.66	3.88	7.88	0.35	3.53	0.24
seminal vesicle, adult	10201-103F3	122.74	4.76	5.29	0.53	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	75.06	0.73	2.67	0.49	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	68.70	3.77	2.26	2.01	2.26	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	64.23	2.01	4.01	2.01	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	96.31	4.30	4.43	0.13	1.07	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	120.03	8.18	11.49	16.47	5.97	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	57.55	2.45	3.10	19.74	1.81	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	150.38	9.93	6.38	0.00	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	97.27	10.43	7.44	2.04	2.64	2.16
skeletal muscle, fetal, donor1	10066-101I3	169.85	7.04	4.02	0.00	4.02	1.01
skin, adult, donor1	10074-102A2	74.64	0.00	6.79	54.28	0.00	0.00
skin, fetal, donor1	10065-101I2	117.41	6.31	3.79	3.79	3.16	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	102.39	6.67	6.34	0.00	4.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	101.50	2.21	3.47	0.00	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	151.89	11.37	12.53	0.00	5.59	3.66
small cell lung carcinoma cell line:LK-2	10541-107H1	103.02	5.60	8.08	0.00	3.13	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	116.78	9.49	5.79	0.00	4.18	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	113.75	9.37	7.19	0.00	1.96	0.22
small intestine, adult, pool1	10024-101D6	130.19	6.69	7.88	12.42	5.02	0.48
small intestine, fetal, donor1	10064-101I1	56.51	2.46	1.97	0.49	1.23	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	85.65	7.18	7.18	0.00	4.62	0.51
smooth muscle, adult, pool1	10048-101G3	139.82	10.08	6.98	1.81	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	62.45	4.29	4.02	0.00	2.68	0.00
spinal cord - adult, donor10196	10181-103D1	86.03	4.13	3.90	0.46	3.67	0.23
spinal cord, adult, donor10252	10159-103A6	117.10	8.67	6.31	0.39	3.94	0.39
spinal cord, adult, donor10258	10369-105F9	109.30	2.08	3.46	0.69	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	121.97	8.54	7.32	0.00	9.15	1.22
spinal cord, newborn, donor10223	10359-105E8	131.79	5.51	9.18	0.46	3.67	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	74.53	2.24	3.29	3.73	1.64	0.60
spleen, adult, pool1	10025-101D7	90.64	3.85	4.07	7.05	1.10	0.66
spleen, fetal, pool1	10044-101F8	159.94	8.82	7.47	7.15	1.67	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	68.94	4.14	3.52	0.10	1.55	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	72.53	4.75	3.04	1.71	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	75.48	2.45	2.10	0.70	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	54.34	2.35	1.95	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	144.75	8.44	9.23	0.00	6.19	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.58	1.69	2.97	0.00	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	103.65	5.92	2.96	29.19	1.69	0.85
stomach, fetal, donor1	10062-101H8	218.93	6.41	4.27	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	101.40	2.85	6.84	0.57	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	107.18	8.10	6.02	0.00	3.12	0.42
substantia nigra, adult, donor10258	10371-105G2	135.52	5.69	10.35	0.00	4.14	0.52
substantia nigra, newborn, donor10223	10358-105E7	109.52	5.65	12.01	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	95.60	8.94	7.11	0.00	8.94	3.67
temporal lobe, adult, pool1	10031-101E4	123.68	7.80	7.46	0.17	8.31	1.53
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	139.60	9.26	14.25	0.00	5.70	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	145.49	10.99	6.59	0.00	3.52	1.32
tenocyte, donor1	11763-123H8	21.64	0.70	2.09	0.00	0.70	0.35
tenocyte, donor2	11765-123I1	28.23	0.38	0.00	0.76	0.76	0.38
tenocyte, donor3	11768-123I4	18.53	1.48	0.37	1.48	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	225.03	8.16	12.92	0.00	7.82	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	89.87	3.24	3.85	0.00	1.70	0.00
teratocarcinoma cell line:PA-1	10807-111A6	143.82	5.11	7.44	0.00	4.80	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	89.88	6.35	7.87	1.52	5.08	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	133.87	6.05	7.94	0.00	4.92	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	74.49	6.98	8.18	3.49	4.47	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	65.79	6.19	11.07	0.00	3.26	0.65
testis, adult, pool1	10026-101D8	127.13	9.56	13.31	1.93	20.08	1.83
testis, adult, pool2	10096-102C6	227.80	10.83	22.55	0.90	40.15	2.71
thalamus - adult, donor10196	10168-103B6	174.43	13.25	1.10	0.00	9.94	0.00
thalamus, adult, donor10252	10154-103A1	119.09	7.81	6.25	0.47	3.28	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	175.52	6.16	1.54	0.00	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	62.25	4.45	4.61	0.00	4.78	0.33
thalamus, newborn, donor10223	10366-105F6	90.33	2.88	4.60	2.30	5.75	0.00
throat, adult	10209-103G2	114.10	3.00	5.49	3.50	2.50	0.50
throat, fetal, donor1	10061-101H7	106.65	3.66	3.96	0.00	3.66	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	138.91	7.35	4.57	0.00	3.58	2.78
thymus, adult, pool1	10027-101D9	164.43	9.05	10.44	0.40	4.08	0.50
thymus, fetal, pool1	10043-101F7	193.68	9.87	7.90	1.56	2.91	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	66.35	1.99	3.32	7.58	1.60	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	82.42	4.89	7.40	1.26	4.05	0.84
thyroid, adult, pool1	10028-101E1	77.36	2.52	3.73	2.89	2.43	0.75
thyroid, fetal, donor1	10060-101H6	116.01	4.75	4.48	0.26	2.90	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	215.57	9.24	6.16	0.00	3.08	0.00
tongue, adult	10203-103F5	66.05	1.16	2.79	3.95	1.86	0.70
tongue, fetal, donor1	10059-101H5	67.78	1.97	2.76	1.58	0.79	0.00
tonsil, adult, pool1	10047-101G2	133.73	6.41	5.31	2.80	2.10	1.30
trachea, adult, pool1	10029-101E2	71.90	3.93	4.58	4.01	1.96	1.39
trachea, fetal, donor1	10058-101H4	91.17	3.08	3.46	0.00	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	96.36	5.31	2.48	0.35	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	119.55	5.98	8.71	2.23	3.04	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	206.04	15.83	18.33	0.00	7.52	1.57
tridermal teratoma cell line:HGRT	10694-109G1	214.99	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	49.27	2.12	2.29	4.15	1.27	0.00
umbilical cord, fetal, donor1	10057-101H3	127.28	4.17	4.17	0.00	4.17	0.00
uterus, adult, pool1	10100-102D1	176.77	16.04	8.02	1.19	1.19	1.71
uterus, fetal, donor1	10055-101H1	92.15	4.10	5.12	8.70	1.54	0.00
vagina, adult	10204-103F6	104.04	4.52	9.69	10.34	1.29	0.00
vein, adult	10191-103E2	104.12	3.51	1.32	1.32	1.97	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	72.37	2.40	2.40	0.00	2.40	0.00